BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 24102369)

  • 41. Daylight-mediated photodynamic therapy of basal cell carcinomas - an explorative study.
    Wiegell SR; Skødt V; Wulf HC
    J Eur Acad Dermatol Venereol; 2014 Feb; 28(2):169-75. PubMed ID: 23294223
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Photodynamic therapy of multiple actinic keratoses: reduced pain through use of visible light plus water-filtered infrared A compared with light from light-emitting diodes.
    von Felbert V; Hoffmann G; Hoff-Lesch S; Abuzahra F; Renn CN; Braathen LR; Merk HF
    Br J Dermatol; 2010 Sep; 163(3):607-15. PubMed ID: 20426780
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Optical coherence tomography imaging of non-melanoma skin cancer undergoing photodynamic therapy reveals subclinical residual lesions.
    Themstrup L; Banzhaf CA; Mogensen M; Jemec GB
    Photodiagnosis Photodyn Ther; 2014 Mar; 11(1):7-12. PubMed ID: 24280439
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Photosensitizers and light sources for photodynamic therapy of the Bowen's disease.
    Calin MA; Diaconeasa A; Savastru D; Tautan M
    Arch Dermatol Res; 2011 Apr; 303(3):145-51. PubMed ID: 21286736
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Topical methyl aminolaevulinate photodynamic therapy for treatment of facial acne vulgaris: results of a randomized, controlled study.
    Hörfelt C; Funk J; Frohm-Nilsson M; Wiegleb Edström D; Wennberg AM
    Br J Dermatol; 2006 Sep; 155(3):608-13. PubMed ID: 16911289
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of red light alone and methyl-aminolaevulinate-photodynamic therapy for the treatment of mild and moderate facial acne.
    Pinto C; Schafer F; Orellana JJ; Gonzalez S; Hasson A
    Indian J Dermatol Venereol Leprol; 2013; 79(1):77-82. PubMed ID: 23254733
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.
    Arits AH; Mosterd K; Essers BA; Spoorenberg E; Sommer A; De Rooij MJ; van Pelt HP; Quaedvlieg PJ; Krekels GA; van Neer PA; Rijzewijk JJ; van Geest AJ; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW
    Lancet Oncol; 2013 Jun; 14(7):647-54. PubMed ID: 23683751
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Methyl aminolaevulinate-photodynamic therapy: a review of clinical trials in the treatment of actinic keratoses and nonmelanoma skin cancer.
    Lehmann P
    Br J Dermatol; 2007 May; 156(5):793-801. PubMed ID: 17419691
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma: a 5 year randomized trial.
    Basset-Seguin N; Ibbotson SH; Emtestam L; Tarstedt M; Morton C; Maroti M; Calzavara-Pinton P; Varma S; Roelandts R; Wolf P
    Eur J Dermatol; 2008; 18(5):547-53. PubMed ID: 18693158
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A randomized split-scalp study comparing calcipotriol-assisted methyl aminolaevulinate photodynamic therapy (MAL-PDT) with conventional MAL-PDT for the treatment of actinic keratosis.
    Torezan L; Grinblat B; Haedersdal M; Valente N; Festa-Neto C; Szeimies RM
    Br J Dermatol; 2018 Oct; 179(4):829-835. PubMed ID: 29476546
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The relationship between protoporphyrin IX photobleaching during real-time dermatological methyl-aminolevulinate photodynamic therapy (MAL-PDT) and subsequent clinical outcome.
    Tyrrell JS; Campbell SM; Curnow A
    Lasers Surg Med; 2010 Sep; 42(7):613-9. PubMed ID: 20806386
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of photodynamic therapy with methyl aminolevulinate in the treatment of superficial and nodular basal cell carcinoma: an open-label trial.
    Surrenti T; De Angelis L; Di Cesare A; Fargnoli MC; Peris K
    Eur J Dermatol; 2007; 17(5):412-5. PubMed ID: 17673385
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effectiveness and safety of 0·5% colchicine cream vs. photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratosis and skin field cancerization of the forearms: a randomized controlled trial.
    Miola AC; Ferreira ER; Lima TRR; Schmitt JV; Abbade LPF; Miot HA
    Br J Dermatol; 2018 Nov; 179(5):1081-1087. PubMed ID: 29862491
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Photodynamic therapy with topical methyl aminolaevulinate for 'difficult-to-treat' basal cell carcinoma.
    Vinciullo C; Elliott T; Francis D; Gebauer K; Spelman L; Nguyen R; Weightman W; Sheridan A; Reid C; Czarnecki D; Murrell D
    Br J Dermatol; 2005 Apr; 152(4):765-72. PubMed ID: 15840111
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Methyl aminolevulinate: actinic keratoses and Bowen's disease.
    Morton CA
    Dermatol Clin; 2007 Jan; 25(1):81-7. PubMed ID: 17126745
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A randomized clinical trial of photodynamic therapy with methyl aminolaevulinate vs. diclofenac 3% plus hyaluronic acid gel for the treatment of multiple actinic keratoses of the face and scalp.
    Zane C; Facchinetti E; Rossi MT; Specchia C; Calzavara-Pinton PG
    Br J Dermatol; 2014 May; 170(5):1143-50. PubMed ID: 24506666
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Photodynamic therapy in combination with CO2 laser for the treatment of Bowen's disease.
    Cai H; Wang YX; Zheng JC; Sun P; Yang ZY; Li YL; Liu XY; Li Q; Liu W
    Lasers Med Sci; 2015 Jul; 30(5):1505-10. PubMed ID: 25899562
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Single versus two-treatment schedule of methyl aminolevulinate daylight photodynamic therapy for actinic keratosis of the face and scalp: An intra-patient randomized trial.
    Gutiérrez García-Rodrigo C; Pellegrini C; Piccioni A; Tambone S; Fargnoli MC
    Photodiagnosis Photodyn Ther; 2019 Sep; 27():100-104. PubMed ID: 31141730
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Penetration enhancement of two topical 5-aminolaevulinic acid formulations for photodynamic therapy by erbium:YAG laser ablation of the stratum corneum: continuous versus fractional ablation.
    Forster B; Klein A; Szeimies RM; Maisch T
    Exp Dermatol; 2010 Sep; 19(9):806-12. PubMed ID: 20636354
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A case of Bowen's disease successfully treated by photodynamic therapy.
    Kosaka S; Kawana S
    J Nippon Med Sch; 2010 Jun; 77(3):136-7. PubMed ID: 20610896
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.